The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Rider F.K.

Soloviev Moscow Research and Clinical for Neuropsychiatry, Moscow, Russia

Danilenko O.A.

Soloviev Research and Practical Psychoneurological Center, Moscow Department of Public Health, Moscow

Grishkina M.N.

Moscow Research and Clinical Center for Neuropsychiatry, Moscow

Kustov G.V.

Soloviev Moscow Research and Clinical for Neuropsychiatry, Moscow, Russia

Akzhigitov R.G.

Serbsky Federal Medical Research Centre for Psychiatry and Narcology;
Soloviev Scientific and Practical Center of Psychoneurology

Lebedeva A.V.

FGBU "Federal'nyĭ nauchnyĭ tsentr transplantologii i iskusstvennykh organov im. akad. V.I. Shumakova" Minzdrava Rossii, Moskva

Guekht A.B.

Moscow Research and Clinical Centre for Neuropsychiatry;
Pirogov Russian National Research Medical University

Depression and epilepsy: comorbidities, pathogenesis, principles of therapy

Authors:

Rider F.K., Danilenko O.A., Grishkina M.N., Kustov G.V., Akzhigitov R.G., Lebedeva A.V., Guekht A.B.

More about the authors

Read: 5700 times


To cite this article:

Rider FK, Danilenko OA, Grishkina MN, Kustov GV, Akzhigitov RG, Lebedeva AV, Guekht AB. Depression and epilepsy: comorbidities, pathogenesis, principles of therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(9‑2):19‑24. (In Russ.)
https://doi.org/10.17116/jnevro20161169219-24

Recommended articles:
Factors of depression acco­rding to acti­graphy in the fall season. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):27-32
Effi­cacy of dupi­lumab application in bullous pemphigoid proceeding in presence of bronchial asthma. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):204-209
Identification of depression biomarkers: Prospects for use in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):51-55
Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12

References:

  1. Lewis AJ. Melancholia: a historical review. J Ment Sci. 1934;80:1-42.
  2. Kanner AM. Depression and Epilepsy: A New Perspective on Two Closely Related Disorders. Epilepsy Currents. 2006;6(5):141-146.
  3. Elliott JO, Lu B, Shneker B, Charyton C, Layne Moore J. Comorbidity, health screening, and quality of life among persons with a history of epilepsy. Epilepsy Behav. 2009;14:1:125-129.
  4. Gaitatzis A, Carroll K, Majeed A, W Sander J. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia. 2004;45:12:1613-1622.
  5. Pulsipher DT, Seidenberg M, Jones J, Hermann B. Quality of life and comorbid medical and psychiatric conditions in temporal lobe epilepsy. Epilepsy Behav. 2006;9:3:511-514.
  6. Strine TW, Kobau R, Chapman DP, Thurman DJ, Price P, Balluz LS. Psychological distress, comorbidities and health behaviors among US adults with seizures. Epilepsia. 2005;46:7:1133-1139.
  7. Téllez-Zenteno JF, Dhar R, Hernandez-Ronquillo L, Wiebe S. Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects. Brain. 2007;130:2:334-345.
  8. Barraclough B. Suicide and epilepsy. In: Reynolds EH, Trimble MR, eds. Epilepsy and psychiatry. Edinburgh: Churchill Livingstone; 1981.
  9. Gilliam F, Kanner A. Treatment of depressive disorders in epilepsy patients. Epilepsy Behav. 2002;3:2-9.
  10. Melikjan Je.G., Geht A.B. Vlijanie komorbidnyh rasstrojstv na kachestvo zhizni bol'nyh jepilepsiej. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2011;111(1):91-97.
  11. Gaitatzis A, Carroll K, Majeed A, W Sander J. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia. 2004;45:12:1613-1622.
  12. Barry JJ, Ettinger AB, Friel P, Gilliam FG, Harden CL, Hermann B, Kanner AM, Caplan R, Plioplys S, Salpekar J, Dunn D, Austin J, Jones J. Advisory Group of the Epilepsy Foundation as part of its Mood Disorder. Consensusstatement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav. 2008;13(suppl 1):1-29.
  13. Hesdorffer DC, Hauser WA, Annegers JF, Cascino G. Majordepression is a risk factor for seizures in older patients. Ann Neurol. 2000;47:246-249.
  14. Adelöw C, Andersson T, Ahlbom A et al. Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy. Neurology. 2012;78(6):396-401.
  15. Hesdorffer DC, Ishihara L, Mynepalli L, Webb DJ, Weil J, Hauser WA. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol. 2012;72:184-191.
  16. Xie W, Cai L, Yu Y et al. Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy. J Neuro in flammation. 2014;11:41.
  17. Chen SD, Wang YL, Liang SF, Shaw FZ. Rapid Amygdala Kindling Causes Motor Seizure and Comorbidity of Anxiety- and Depression-Like Behaviors in Rats. Front Behav Neurosci. 2016;10:129.
  18. Vujisić S, Vodopic S, Radulovic L et al. Psychiatric comorbidities among patients with epilepsy in Montenegro. Acta Clin Croat. 2014;53:411-416.
  19. Bosak M, Dudek D, Siwek M et al. Subtypes of interictal depressive disorders according to ICD-10 in patients with epilepsy. Neurol Neurochir Pol. 2015;49:90-94.
  20. Lambert MV, Robertson MM. Depression in Epilepsy: Etiology, Phenomenology and Treatment. Epilepsia. 1999;40(suppl 10):21-47.
  21. Swinkels W A, van Emde Boas W, Kuyk J et al. Interictal depression, anxiety, personality traits, and psychological dissociation in patients with temporal lobe epilepsy (TLE) and extra-TLE. Epilepsia. 2006;47:2092-2103.
  22. Kapitany T, Glauninger G, Schimka B. Psychiatrische Aspekte. In: Handbuch der Epilepsien. C. Baumgartner (Hrsg.). Springer, Wien. 2001;246-256.
  23. Wolf P. Praxisbuch Epilepsien. Diagnostik, Behandlung, Rehabilitation. Stuttgart: Kohlhammer; 2003.
  24. Baker GA. The psychosocial burden of epilepsy. Epilepsia. 2002;43(suppl 6):26-30.
  25. Jacoby A. Epilepsy and the quality of everyday life. Findings from a study of people with well-controlled epilepsy. Soc Sci Med. 1992;34:657-666.
  26. Kobau R, Price P. Knowledge of epilepsy and familiarity with this disorder in the U.S. population: results from the 2002 Health Styles Survey. Epilepsia. 2003;44:1449-1454.
  27. Blume WT, Derry PA. Stigma and its neurological and psychological effects in epilepsy. Can J Neurol Sci. 2008;35:403-404.
  28. Mil'chakova L.E., Mizinova M.A., Geht A.B., Lebedeva A.V. Stigmatizacija i social'naja adaptacija bol'nyh jepilepsiej. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova (Prilozhenie «Jepilepsija»)» 2011;111(5):58-62.
  29. England MJ, Austin JK, Beck V, Escoffery C, Hesdorffer DC. Erasing epilepsy stigma: eight key messages. Health Promot Pract. 2014;15:313-318.
  30. Morrell MJ. Stigma and epilepsy. Epilepsy Behav. 2002;3:21-25.
  31. McLin WM, de Boer HM. Public perceptions about epilepsy. Epilepsia. 1995;36:957-959.
  32. Melikjan Je.G., Geht A.B. Kachestvo zhizni bol'nyh jepilepsiej. Lechebnoe delo. 2011;1:1-9.
  33. Fiest KM, Birbeck GL, Jacoby A, Jette N. Stigma in epilepsy. Curr Neurol Neurosci Rep. 2014;14:1-6.
  34. Kobau R, Luncheon C, Zack MM, Shegog R, Price PH. Satisfaction with life domains in people with epilepsy. Epilepsy Behav. 2012;25(4):546-551.
  35. Kazennyh T.V., Semke V.Ja. Psihoterapevticheskaja korrekcija v sisteme kompleksnoj terapii bol'nyh jepilepsiej. Bjulleten' SO RAMN. 2006;1(119).
  36. Austin JK, Hesdorffer DC, Liverman CT, Schultz AM. Testimony Group. Testimonies submitted for the Institute of Medicine report: epilepsy across the spectrum: promoting health and understanding. Epilepsy Behav. 2012;25(4):634-661.
  37. Kimiskidis Vasilios K et al. Depression and anxiety in epilepsy: the association with demographic and seizure—related variables. Annals of General Psychiatry. 2007;6:28.
  38. Covanis A, Guekht A, Li S, Secco M, Shakir R, Perucca E. From global campaign to global commitment: The World Health Assembly's Resolution on epilepsy. Epilepsia. 2015;56(11):1651-1657.
  39. Kalinin V.V., Zheleznova E.V. Protivosudorozhnye i psihotropnye svojstva antijepilepticheskih preparatov pri lechenii bol'nyh jepilepsiej. M.: Artinfopablishing; 2008.
  40. Dudra-Jastrzebska M, Andres-Mach MM, Łuszczki JJ, Czuczwar SJ. Mood disorders in patients with epilepsy. Pharmacological reports. 2007;59:369-378.
  41. Andersohn F, Schade R, Willich SN et al. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology. 2010;75:335-340.
  42. Machado RA, Espinosa AG, Melendrez D et al. Suicidal risk and suicide attempts in people treated with antiepileptic drugs for epilepsy. Seizure. 2011;20:280-284.
  43. Mula M, Trimble MR, Sander JW. The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia. 2003;44:1573-1577.
  44. Mula M, Hesdorffer DC, Trimble M et al. The role of titration schedule of topiramate for the development of depression in patients with epilepsy. Epilepsia. 2009;50:1072-1076.
  45. Mula M, Trimble M R, Yuen A et al. Psychiatric adverse events during levetiracetam therapy. Neurology. 2003;61:704-706.
  46. Tao K, Wang X. The comorbidity of epilepsy and depression: diagnosis and treatment. Expert Review of Neurotherapeutics. 2016:1-13.
  47. Wrench JM, Wilson SJ, O'Shea MF et al. Characterising de novo depression after epilepsy surgery. Epilepsy Res. 2009;83:81-88.
  48. Paparrigopoulos T, Ferentinos P, Brierley B et al. Relationship between post-operative depression/anxiety and hippocampal/amygdala volumes in temporal lobectomy for epilepsy. Epilepsy Res. 2008;81:30-35.
  49. Kanner AM, Gilliam FG, Barry J, Hermann B, Meador KJ. Differential impact of mood and anxiety disorders on the quality of life and perception of adverseevents to antiepileptic drugs in patients with epilepsy. In: Abstracts from. Annual Meeting of the American Epilepsy Society. Epilepsia. 2007;48(6).Program 1.283. Philadelphia: American Epilepsy Society; 2007.
  50. Ridsdale L, Charlton J, Ashworth M, Richardson MP, Gulliford MC. Epilepsy mortality and risk factors for death in epilepsy: a population-based study. Br J Gen Pract. 61:271-278.
  51. Mil'chakova L.E., Mizinova M.A., Magomedova A.H., Shpak A.A., Geht A.B. Sovremennoe sostojanie problemy «stoimosti bolezni» pri jepilepsii. Zhurnal nevrologii i psihiatrii im. C.C. Korsakova. 2013;113(1):82-84.
  52. Burd S.G., Rider F.K., Badaljan O.L., Avakjan G.G., Chukanova A.S. Depressija i jepilepsija: dve storony odnoj medali. Russkij medicinskij zhurnal Nevrologija. 2008;16:12:1-5.
  53. Lebedeva A.V. Osobennosti depressii u pacientov s jepilepsiej. Russkij medicinskij zhurnal. 2007;10:892.
  54. Loring DW, Meador KJ. Cognitive and Behavioral Effects of Epilepsy Treatment. Epilepsia. 2001;42(suppl 8):24-32.
  55. Kraepelin E. Psychiatrie. Band 3. Leipzig: Johann Ambrosius Barth. 1923.
  56. Bleuler E. Lehrbuch der Psychiatrie, 8th edn. Berlin: Springer-Verlag; 1949.
  57. Blumer D. Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders. Harv Rev Psychiatry. 2000;8:8-17.
  58. Mula M, Jauch R, Cavanna A, Collimedaglia L, Barbagli D, Gaus V, Kretz R, Viana M, Tota G, Israel H, Reuter U, Martus P, Cantello R, Monaco F, Schmitz B. Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. Epilepsia. 2008;49:650-656.
  59. Vorob'eva O.V., Skripkin A.Ju. Depressija u pacientov, stradajushhih jepilepsiej (osobennosti fenomenologii i podhody k lecheniju). Lechebnoe delo. 2010;2:96-104.
  60. Blanchet P, Frommer GP. Mood change prece¬ding epileptic seizures. J Nerv Ment Dis. 1986;174:471-476.
  61. Kanner A, Nieto J. Depressive disorders in epilepsy. Neurology. 1999;53(suppl 2):26-32.
  62. Williams D. The structure of emotions reflected in epileptic experiences. Brain. 1956;79:29-67.
  63. Kanner A, Soto A, Gross-Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology. 2004;62:708-713.
  64. Kalinin V.V. Affektivnye i trevozhnye rasstrojstva u bol'nyh jepilepsiej: voprosy fenomenologii i adekvatnoj terapii. Vestnik jepileptologii. 2008;1:13-17.
  65. Mendez MF, Cummings JL, Benson DF. Depression in epilepsy. Significance and phenomenology. Arch Neurol. 1986;43:766-770.
  66. Mula M. Chapter 9 The interictal dysphoric disorder. The neuropsychiatry of epilepsy 2nd. Eds. Trimble M.R., Schmitz B. Cambridge University Press. 2011;80-89.
  67. Kanner AM, Kozak AM, Frey M. The use of sertralin in patients with epilepsy: is it safe. Epilepsy Behav. 2000;1(2):100-105.
  68. Kanner AD, Ribot R. Depression. In: Neuropsychiatric Symptoms of Epilepsy. Mula M. Editor. Springer International Publishing Switzerland. 2016;25-41.
  69. Barry J, Lembke A, Huynh N. Affective disorders in epilepsy. In: Psychiatric issues in epilepsy. A practical guide to diagnosis and treatment. Eds. Ettinger A., Kanner A. LWW, Philadelphia. 2001;45-71.
  70. Grishkina M.N., Danilenko O.A., Gersamija A.G., Kustov G.V., Akzhigitov R.G., Kazimirova E.A., Geht A.B. Depressija u bol'nyh jepilepsiej. V kn.: Bolezni mozga-medicinskie i social'nye aspekty. Pod. red. Guseva E.I., Geht A.B. M.: OOO «Buki-Vedi»; 2016.
  71. Mil'chakova L.E., Geht A.B. Novye lekarstvennye preparaty v terapii vzroslyh pacientov s refrakternoj jepilepsiej. Zhurnal nevrologii i psihiatrii (Prilozhenie «Jepilepsija»). 2011;10:52-56.
  72. Ketter TA, Malow BA, Flamini R, White SR, Post RM, Theodore WH. Anticonvulsant withdrawal- emergent psychopathology. Neurology. 1994;44(1):55-61.
  73. Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007;62:345-354.
  74. Martinovic Z, Simonovic P, Djokic R. Preventing depression in adolescents with epilepsy. Epilepsy Behav. 2006;9:619-624.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.